P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE KINASE INHIBITOR THERAPIES

Detalles Bibliográficos
Autores principales: Lang, Fabian, Branford, Susan, P. Lyssikatos, Joseph, Collins, Helen, Hochhaus, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428795/
http://dx.doi.org/10.1097/01.HS9.0000969636.32603.d4
Descripción
Sumario:

Ejemplares similares